Eaton Vance Management Argenx Se Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Argenx Se stock. As of the latest transaction made, Eaton Vance Management holds 348,522 shares of ARGX stock, worth $316 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

348,522

Previous 347,128 0.4%

Holding current value

$316 Million

Previous $132 Million 6.44%

% of portfolio

0.18%

Previous 0.18%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $478,420 - $551,675	1,394 Added 0.4%	348,522 $123 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $16,174 - $22,732	-60 Reduced 0.02%	347,128 $132 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $1,526 - $2,106	6 Added 0.0%	347,188 $109 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $1,632 - $2,118	6 Added 0.0%	347,182 $122 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $3.18 Million - $3.78 Million	-10,768 Reduced 3.01%	347,176 $105 Million

Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $17,226 - $21,434	-67 Reduced 0.02%	357,944 $108 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $13.1 Million - $18.6 Million	-48,889 Reduced 12.01%	358,011 $98.6 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $355,074 - $441,263	-1,431 Reduced 0.35%	406,900 $120 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $818,938 - $1.04 Million	-3,800 Reduced 0.92%	408,331 $107 Million
Q2 2020 Nov 20, 2020	SELL	$127.44 - $232.72 $1,274 - $2,327	-10 Reduced -0.0%	412,131 $92.8 Million
Q2 2020 Aug 13, 2020	SELL	$127.44 - $232.72 $65,249 - $119,152	-512 Reduced 0.12%	412,141 $92.8 Million
Q1 2020 May 14, 2020	SELL	$108.83 - $165.23 $26,445 - $40,150	-243 Reduced 0.06%	412,653 $54.4 Million
Q4 2019 Feb 11, 2020	SELL	$106.59 - $164.21 $11,085 - $17,077	-104 Reduced 0.03%	412,896 $66.3 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $7.87 Million - $10.5 Million	69,498 Added 20.23%	413,000 $47.1 Million
Q2 2019 Nov 21, 2019	BUY	$115.0 - $141.58 $14,375 - $17,697	125 Added 0.04%	343,502 $48.6 Million
Q2 2019 Aug 16, 2019	BUY	$115.0 - $141.58 $18.4 Million - $22.6 Million	159,632 Added 86.88%	343,377 $48.6 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $18.2 Million - $24.7 Million	183,745 New	183,745 $22.9 Million

Others Institutions Holding ARGX

# of Institutions

535

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Argenx Se Transaction History